Barnes PJ. Molecular mechanisms and cellular effects of glucocorticoids. Immunol Allergy Clin North Am. 2005, vol.25, p451-468.
Malkinson FD. Studies on the percutaneous absorption of C14 labeled steroids by use of the gas-flow cell. J Invest Dermatol. 1958, vol. 31, 19-28.
Boguniewicz M. Conventional topical therapy of atopic dermatitis. Atopic Dermatitis (Bieber T, et al, ed.), Mercel Dekker Inc, 2002.
アトピー性皮膚炎ガイドライン, 2018
Feldmann RJ. Regional variation in percutaneous penetration of 14C cortisol in man, J invest Dermatol. 1967, vol.48, no. 2, p181-183.
島雄周平. ステロイド外用剤の外用期間と外用方法. 日本医事新報. 1993, vol. 3625, p135-136.
島雄周平. 外用ステロイド剤による全身的影響. Therapeutic Research. 1988, vol. 8, p222-231.
相馬良直. ステロイド外用薬を長く使っていますが、副作用は大丈夫でしょうか。 皮膚科の臨床. 2021, vol. 63, no. 6, p734-737.
有川順子. アトピー性皮膚炎患者の眼圧と顔面へのステロイド外用療法との関連性についての検討. 日皮会誌. 2002, vol.112, p1107-1110.
Chi CC. Risk of intrauterine growth retardation, malformations and other birth outcomes in children after topical use of corticosteroid in pregnancy. Acta Obstet Gynecol Sand. 2002, vol.81, p234-239.
Butler DC. Safety of dermatologic medications in pregnancy and location: Part Ⅱ. Location. J Am Acad Dermatol. 2014, vol. 70, no. 417, e1-e10.
